← SynDRA
Lopac-B-175
SynDRA canonical compound SYN0695301 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | HTR2B |
|---|
| Mechanism of action | Serotonin receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- Serotonin receptor agonist
- HTR2A FULL AGONIST
- HTR2B FULL AGONIST
- HTR2C FULL AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- APOBEC3F
- ATXN2
- BAZ2B
- GMNN
- L3MBTL1
- PLK1
- POLH
- POLI
- POLK
- RAPGEF3
- VDR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- NCGC00015135-01
- Tocris-1059
- NCGC00015135-02
- NCGC00024972-01
- alpha-methyl-5-(2-thienylmethoxy)-1H-indole-3-ethanamine
- NCGC00015135-05
- Tox21_500761
- BW-723C86?
- T21625
- NCGC00093688-01
- NCGC00024972-03
- CAS_5311036
- B-175
- BW-72386
- NCGC00015135-12
- CCG-204312
- C16H19ClN2OS
- HY-101369
- CCG-222065
- SDCCGSBI-0050205.P002
- MFCD01321066
- UNII-8JMH6M2ELN
- BDBM82472
- NCGC00015135-04
- 8JMH6M2ELN
- SR-01000075731
- SR-01000075731-7
- GLXC-06870
- MLS000862196
- BRD-A17428743-001-01-1
- SMR000326959
- RefChem:917779
- SCHEMBL29779332
- CHEBI:91556
- BW723C86
- BW-723C86
- SR-01000075731-1
- SCHEMBL7638580
- LP00761
Look up Lopac-B-175 in the interactive SynDRA portal →